Associated Papers
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.
Tantawy SI et al.
Blood Cancer Journal, 2025
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib.
Aslan B et al.
Blood Advances, 2024
38968154 (PubMed )
Supplement: BLOODA_ADV-2023-012360-mmc1.pdf
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.
Kang J et al.
Signal Transduction and Targeted Therapy, 2021
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
Tausch E et al.
Haematologica, 2020
33054084 (PubMed )
Supplement: 2019.229161.TAUSCH_SUPPL.pdf
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia.
Bretones G et al.
Blood, 2018
Select a paper to view details